Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients

Nicola Tarantino, Domenico G. Della Rocca, Fengwei Zou, Aung Lin, Andrea Natale, Luigi Di Biase

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


We review the current data on epidemiology, the clinical significance, the pathophysiologic mechanisms, and the treatment of VAs in the setting of COVID-19. VAs prevail in 0.15% to 8% of hospitalized patients, but only sustained and rapid tachyarrhythmias are purportedly associated with a significant increase in mortality. Multiple factors can elicit VAs, which are ultimately deemed to be a marker of severe systemic disease rather than a distinct cardiac condition. Even though the electrophysiologist plays a determinant role in the secondary prevention of VAs, a multidisciplinary approach is indispensable for primary prophylaxis and acute management.

Original languageEnglish (US)
Pages (from-to)11-20
Number of pages10
JournalCardiac Electrophysiology Clinics
Issue number1
StatePublished - Mar 2022


  • Arrhythmias
  • COVID-19
  • Complications
  • Management
  • Outcomes
  • SARS-CoV-2
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


Dive into the research topics of 'Prevalence, Outcomes, and Management of Ventricular Arrhythmias in COVID-19 Patients'. Together they form a unique fingerprint.

Cite this